Whats ahead for Nvidia in life sciences in 2025
2024has been a good year for US-based technology powerhouse Nvidia. The company has come a long way from their starting…
All articles by Joshua Silverwood
Joshua Silverwood
-
-
Medtech’s manufacturing bottlenecks and how they can be broken
Although the medical device industry has seen nothing but growth over the past few decades, that same growth has been…
-
CEO of UnitedHealthcare, Brian Thompson, shot dead in New York City
The CEO of US healthcare insurance firm UnitedHealthcare Group has been shot dead by a masked gunman outside of the…
-
Telix Pharma doses first patient in Phase III PET carcinoma trial
Australian biotechnology company, Telix Pharmaceuticals, has announced that it has dosed the first patient as part of its Phase III…
-
BioInteliSense remote cardiac device cuts hospital time in trial
Colorado remote patient monitoring firm, BioIntelliSense’s chest-mounted BioButton designed to monitor a range of vital signals can cut hospital times,…
-
Edwards Lifesciences announces positive results in one year TAVI trial
US medical device giant Edwards Lifesciences has said patients are experiencing “outstanding one-year outcomes” and lower rates of mortality after…
-
Can more investment save the NHS from failing technology?
In the weeks and months since Keir Starmer’s government took the reins in the UK, promises have been made as…
-
MHRA calls for industry input on keeping EU law, IVD classification & more
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has launched a consultation period calling on the public and private…
-
MED-EL bags expanded clearances for hearables system
North Carolina-based hearables company, MED-EL Corporation, has secured clearance from the US Food and Drug Administration (FDA) for a range…
-
Vivolta teams up with Neurochase to manufacture electrospun micro-catheters
Netherlands-based medical electrospinning company Vivolta has signed a long-term partnership with UK company Neurochase to manufacture micro-catheters thatdeliver advanced therapies…